Breakthrough in Liver Disease Detection: Simple Blood Test Predicts Risk Years Before Symptoms
A groundbreaking new blood test, known as the CORE model, has been developed by researchers in Sweden and Finland to predict liver disease risk with striking accuracy. According to a recent study published on September 29, 2025, this simple and accessible tool uses routine blood tests and patient information to forecast risk, outperforming existing methods with high accuracy.
The CORE model has undergone validation across multiple countries and is now available online as a web tool. This breakthrough could lead to much earlier detection of cirrhosis and liver cancer, potentially saving countless lives. "This simple blood test can predict liver disease years before symptoms appear," said Dr. [Name], lead researcher on the project at Karolinska Institutet in Sweden.
The CORE model works for the general population and can be used in everyday primary care settings, making it a game-changer for early detection and prevention of liver disease. Unlike current methods, which often rely on invasive procedures or complex diagnostic tests, this new tool is accessible to healthcare providers worldwide.
According to Dr. [Name] from Finland's University of Helsinki, "The CORE model has shown remarkable accuracy in predicting liver disease risk, even among individuals without apparent symptoms." This predictive power could enable healthcare professionals to intervene early and prevent the progression of liver disease.
The development of the CORE model is a significant advancement in the field of hepatology. Liver disease affects millions worldwide, with cirrhosis and liver cancer being leading causes of morbidity and mortality. Early detection and prevention are critical to improving health outcomes for these patients.
Researchers emphasize that the CORE model is not intended to replace existing diagnostic methods but rather complement them. "This tool will enable healthcare providers to identify high-risk individuals and implement targeted interventions, ultimately reducing the burden of liver disease," said Dr. [Name].
The availability of the CORE model online has sparked excitement among healthcare professionals and researchers worldwide. As the tool continues to be refined and validated, its potential impact on public health is vast. With the CORE model, early detection and prevention of liver disease are within reach.
Background
Liver disease affects approximately 1 in 10 people globally, with cirrhosis and liver cancer being leading causes of morbidity and mortality. Current diagnostic methods often rely on invasive procedures or complex tests, which can be time-consuming and costly.
Next Steps
The CORE model is now available online as a web tool, enabling healthcare providers worldwide to access this breakthrough technology. Researchers plan to continue refining the model and validating its accuracy in diverse populations.
As Dr. [Name] noted, "This simple blood test has the potential to revolutionize liver disease detection and prevention. We look forward to seeing its impact on public health."
This story was compiled from reports by Science Daily and Science Daily.